[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-CRVO":3,"homepage-market-summary":30,"stock-news-CRVO":172},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"CRVO","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"CervoMed Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.","15","Boston, MA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":18,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":26,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},3.02,2.96,3.07,2.8813,2.93,0.09,211291.499177,1393,2.9776,10,2.13,1485466.724569272,11.3,4619,{"status":31,"indices":32,"watchlist":76,"sectors":98,"benchmarks":154},"success",[33,41,48,55,62,69],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":39,"sparkline":40,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":39,"sparkline":47,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":39,"sparkline":54,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":60,"is_up":39,"sparkline":61,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":63,"name":64,"price":65,"change":66,"pct_change":67,"is_up":39,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":14,"sparkline":75,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":39,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":39,"sparkline":90,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":39,"sparkline":97,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[99,104,109,114,119,124,129,134,139,144,149],{"name":100,"etf":101,"change":102,"price":103,"is_up":39},"Technology","XLK",1.01,199.81,{"name":105,"etf":106,"change":107,"price":108,"is_up":39},"Financials","XLF",0.06,53.49,{"name":110,"etf":111,"change":112,"price":113,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":115,"etf":116,"change":117,"price":118,"is_up":39},"Consumer Cycl","XLY",1.13,110.04,{"name":120,"etf":121,"change":122,"price":123,"is_up":39},"Consumer Staples","XLP",0.25,80.53,{"name":125,"etf":126,"change":127,"price":128,"is_up":39},"Energy","XLE",0.4,62.95,{"name":130,"etf":131,"change":132,"price":133,"is_up":39},"Industrials","XLI",0.78,169.95,{"name":135,"etf":136,"change":137,"price":138,"is_up":39},"Materials","XLB",0.66,48.86,{"name":140,"etf":141,"change":142,"price":143,"is_up":39},"Real Estate","XLRE",0.32,40.81,{"name":145,"etf":146,"change":147,"price":148,"is_up":39},"Utilities","XLU",0.38,39.83,{"name":150,"etf":151,"change":152,"price":153,"is_up":39},"Comm Services","XLC",0.35,110.32,[155,160,164,168],{"ticker":156,"name":157,"price":158,"change":159,"is_up":39},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":161,"name":162,"price":163,"change":89,"is_up":39},"QQQ","Invesco QQQ Trust",749.58,{"ticker":165,"name":166,"price":167,"change":53,"is_up":39},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":169,"name":170,"price":171,"change":67,"is_up":39},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":173,"articles":174},8,[175,181,187,193,199,204,210,215],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"CRVO Stock Rockets Nearly 100% On Patent Win Before Offering News Cools Rally - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi6gFBVV95cUxQLUY0VGNvdlhtZlMxeU5kMlc3Vnd6aTRMSmR0NTNldXozVVdzdF8xc1FiZVhLTVd0QWdFZFVCUzZCRFltWG5rM1FzUDhTTUZQWkVOR3dWME9SODRqQk5CM3RzbWp4clRFdldDV1hlUUxUcGtGU1pRQUtPUTlIRmdKWF95RWJvNFBPYWo4eHM2LWRJYnl2LXFXbUFFWVlvNWRrZjBIRFdPZkNsNXVNd3FLU0NnaUc1b2JERGNHa2FtdGJORkFEenB3RC1CaTRCV0p3cS1aaElnWTgxTVk0T1V2RnZZQ2Ztc3A3c0E?oc=5","Thu, 01 Oct 2026 00:09:28 GMT","CRVO Stock Rockets Nearly 100% On Patent Win Before Offering News Cools Rally Stocktwits","Stocktwits",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"The new tablet had about 20% lower peaks and about 20% higher levels at 12 hours than the old capsule. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxNT2Q0RFBGQ1ZIem10ME9CdXE3eDk2ZVFpd2QwNlBvN3FreFV0aEtMSGxZZW92UFBHSUhxZDBtWVkwcW1BNEs1dGVXcTNBR2RJcnM4cWdfelIyUkF5MkxoVmt4MWR6T1hFNVRsLWxGaThXR2JnVXFJRVBHY0dGX3RYa1AwcTU3SURxN0VkQTRLZnBGdmhHdUZKakxUaVJRNU9QbjVrdndKNmNaYU5oSkg5NkZCMnVWZzY0U3FMVg?oc=5","Mon, 28 Sep 2026 11:30:00 GMT","The new tablet had about 20% lower peaks and about 20% higher levels at 12 hours than the old capsule. Stock Titan","Stock Titan",{"title":188,"link":189,"pubDate":190,"description":191,"source":192},"Hopeful Week For Insiders Who Bought US$3.46m Of CervoMed Stock - simplywall.st","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Thu, 01 Oct 2026 11:03:31 GMT","Hopeful Week For Insiders Who Bought US$3.46m Of CervoMed Stock simplywall.st","simplywall.st",{"title":194,"link":195,"pubDate":196,"description":197,"source":198},"CervoMed (CRVO) Advances Neflamapimod Development with New 50 mg Tablet and FDA Update - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwAFBVV95cUxQQXhKak9tYzVMcHh6N3dkVGFsNy1LVGluNDVoNVRWMWdSampoUVdFdUl6cGRmNTVwMFhUakhuemhFUHpiM0M3Qk9qUmVNNUxxRXJuZkRlOVJkX2dOX1p6QXYtNjhYdFFnNUJwMm5MbjV1bHpFMGx6NlVwbEszdC1nT2U3Z2c3d01lMi1QTmthdGloT1lOc1A0Ulg3dkMxbjJTSTlTRTJyVXhtMTlYRDRjbGM3QzhxR1RDZlFwM1ZCM1g?oc=5","Mon, 28 Sep 2026 12:44:43 GMT","CervoMed (CRVO) Advances Neflamapimod Development with New 50 mg Tablet and FDA Update GuruFocus","GuruFocus",{"title":200,"link":201,"pubDate":202,"description":203,"source":180},"Nasdaq, S&P 500, Dow Futures Rebound Ahead Of PPI Data Even As Iran Tensions Simmer: Why ORCL, CRWV, ADBE, BATL, MU, ADTX Are In Focus - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi_wFBVV95cUxPc3ptOEUtdDdJbGhHLVkwREtJX05JNUxLcGVFb24tZl9ZcEhwTTJNT3VTcTBqalJ6SFJkcEVwU0tXQ1VfZWI4T3VQc3dBWVVIczFrRW4zRERkTXpmZnllNlh4ZHRJZGNmVlZ4SjB1cGZ1X19SYnoxdVJXa2NsMlNhMXlaS05KSEV5akI3Qm9DNU85VDlNcTlXSUw1LXpLSG9yVnpiVm5KY0hVdHJHSi0zWm5Ya2NFendHbUJxdUtzalpORkJVUmh1bFp2VGpqdWFGZGUtb2lIeTdUS3k5NDB0MElteGVnN0lhY2dVWXdveXprRERGcVVrVE00bXd6emM?oc=5","Fri, 02 Oct 2026 17:28:47 GMT","Nasdaq, S&P 500, Dow Futures Rebound Ahead Of PPI Data Even As Iran Tensions Simmer: Why ORCL, CRWV, ADBE, BATL, MU, ADTX Are In Focus Stocktwits",{"title":205,"link":206,"pubDate":207,"description":208,"source":209},"CervoMed advances higher-dose neflamapimod formulation By Investing.com - Investing.com Nigeria","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitAFBVV95cUxNTDRhazdfZFR5UkwtWkxzMVhQUU5MMWZual9xdlJlOTFFN1JmMVpiU3VEb1k0N2FzRmRmSE9QM2dXT0REaVFfWjBnLU1nSkM0THhWQ0syTHlYUUp4amlJUW9zOElIRWswMjBzVUNQUnpzbzMwWVg3eG1SSWdmd3VsZ0xFUnljZFc3ck5FZ1RjZENPY1VucmNxMkxLaHFzbWFaLS1yYlo4eG00cVRoblV1VmlQeGo?oc=5","Mon, 28 Sep 2026 12:12:53 GMT","CervoMed advances higher-dose neflamapimod formulation By Investing.com Investing.com Nigeria","Investing.com Nigeria",{"title":211,"link":212,"pubDate":213,"description":214,"source":198},"FDA Lifts Neflamapimod Dosage Restriction, Boosting CervoMed (CR - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiswFBVV95cUxQR3BiVnpZM3U4UkhFWnNveTZKMk9ERUxVWW5OZDZ5NjNadWgzN0RMNUpYOFRCVVBjUVVJWUZONFdBR2hiRDJIQ1JsRnAxa0R3WHRoblRkLUtHMi1zbUVma052cDZPTWRScmF4dlhHTEZyd2hCMi1DMlBGNmNQcVI4SG1TcDVQcXhIN245Nm9zTzh2Z29aZEZzUTNhVy1nUFRuV3NBRXl3MjVmZFFrTEZHOXFZbw?oc=5","Mon, 28 Sep 2026 15:12:33 GMT","FDA Lifts Neflamapimod Dosage Restriction, Boosting CervoMed (CR GuruFocus",{"title":216,"link":217,"pubDate":218,"description":219,"source":220},"CervoMed Advances Neflamapimod Tablet and Dosing Strategy - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirgFBVV95cUxPOWlIaXoxRW1xN21jeXdYQVlPRnZ3UlMwUFdfOGJYQlE0VG1qblhwQmpaRW93TWNmTHlqQlBBOERRSTdmRVZxNHBrb3RxNFdETS1oeVVOOXpXd1hiM1RCdlN6Um14N295UXRFLVpVb2I5dVlZX01qVlZfd0h3eU9sbWRjTDB4MmNXQVpxQjVnZHJ3UGFaMEstNG95eHp6U3E4dXphMVZLN3Nyd3NuX1E?oc=5","Mon, 28 Sep 2026 21:44:46 GMT","CervoMed Advances Neflamapimod Tablet and Dosing Strategy TipRanks","TipRanks"]